5 completed. 5 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
| Phase 1 | 3 | Completed 3 |
Follow linrodostat: new trials by email Literature Review of linrodostat trials Research Report on linrodostat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of BMS-986205 Alone and in Combination With Nivolumab in Chinese Patients With Advanced Malignant Solid Tumors BMS-986205, Nivolumab - Advanced Cancer | Phase 1 / Phase 2 | Completed | Bristol-Myers Squibb | 12 | 2018-12-31 | 2022-02-28 |
| An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have Spread Relatlimab, Nivolumab, BMS-986205 - Advanced Cancer | Phase 1 / Phase 2 | Completed | Bristol-Myers Squibb | 229 | 2018-05-30 | 2026-04-06 |
| A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma Nivolumab, Ipilimumab, Relatlimab - Advanced Cancer | Phase 2 | Completed | Bristol-Myers Squibb | 182 | 2017-02-02 | 2022-12-19 |
| A Study to Test Combination Treatments in Participants With Advanced Gastric Cancer Nivolumab, Ipilimumab, Relatlimab - Advanced Gastric Cancer | Phase 2 | Completed | Bristol-Myers Squibb | 190 | 2016-11-29 | 2023-06-09 |
| An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread BMS-986205, Nivolumab, Ipilimumab - Advanced Cancer, Melanoma | Phase 1 / Phase 2 | Completed | Bristol-Myers Squibb | 627 | 2016-04-14 | 2023-08-28 |
Carcinoma, Non-Small-Cell Lung (1) · Melanoma (1)
Australia (4) · Italy (4) · United States (4) · Canada (3) · France (2) · Germany (2) · Israel (2) · Spain (2) · Switzerland (2) · Austria (1) · China (1) · Finland (1) · Netherlands (1) · Norway (1) · Poland (1)
2016 (2), 2015 (1), 2018 (1)